This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The Cleveland Clinic Foundation, The University of Texas System, Washington University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,075 
1 out of 5,640 
1 out of 1,383 
Years Active: 2025
Title: Matthew Gorman: Innovator in Glioma Treatment
Introduction
Matthew Gorman is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of medical research, particularly in the treatment of glioblastoma. His innovative approach utilizes Zika virus strains to combat this aggressive form of brain cancer.
Latest Patents
Matthew Gorman holds 1 patent for his work on Zika virus strains for the treatment of glioma. The patent details a composition and method for treating glioblastoma using the Zika virus, showcasing a novel approach to a challenging medical issue.
Career Highlights
Throughout his career, Gorman has worked with prestigious institutions such as Washington University and The Cleveland Clinic Foundation. His research has focused on developing innovative therapies that leverage viral mechanisms to target cancer cells effectively.
Collaborations
Matthew has collaborated with notable colleagues, including Michael S. Diamond and Milan Chheda, who have contributed to his research endeavors.
Conclusion
Matthew Gorman's work exemplifies the intersection of innovation and medical research, particularly in the fight against glioblastoma. His contributions are paving the way for new treatment methodologies that could significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile